MESNEX Drug Patent Profile
✉ Email this page to a colleague
When do Mesnex patents expire, and what generic alternatives are available?
Mesnex is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in MESNEX is mesna. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mesna profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mesnex
A generic version of MESNEX was approved as mesna by FRESENIUS KABI USA on April 26th, 2001.
Summary for MESNEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 120 |
Clinical Trials: | 89 |
Patent Applications: | 1,250 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MESNEX |
What excipients (inactive ingredients) are in MESNEX? | MESNEX excipients list |
DailyMed Link: | MESNEX at DailyMed |
Recent Clinical Trials for MESNEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ossium Health, Inc. | Phase 1/Phase 2 |
Center for International Blood and Marrow Transplant Research | Phase 1/Phase 2 |
Center for International Blood and Marrow Transplant Research | Phase 1 |
Pharmacology for MESNEX
Drug Class | Cytoprotective Agent |
Anatomical Therapeutic Chemical (ATC) Classes for MESNEX
US Patents and Regulatory Information for MESNEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MESNEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MESNEX
See the table below for patents covering MESNEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 129894 | Tablet and granulate containing mesna as active agent | ⤷ Try a Trial |
Canada | 2107961 | SOLUTIONS MESNA INJECTABLES (INJECTABLE MESNA SOLUTIONS) | ⤷ Try a Trial |
South Korea | 100364466 | ⤷ Try a Trial | |
Austria | A871078 | ⤷ Try a Trial | |
Czech Republic | 9302097 | ⤷ Try a Trial | |
Finland | 913409 | ⤷ Try a Trial | |
New Zealand | 238941 | GRANULAR COMPOSITIONS CONTAINING SODIUM 2-MERCAPTO ETHANE SULPHONATE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |